MGI(SH:688114) Xin Lang Cai Jing·2026-01-13 03:32Group 1 - The core viewpoint of the news is that BGI Genomics has seen a significant stock price increase, with a 5.08% rise on January 13, reaching 82.78 yuan per share, and a total market capitalization of 34.479 billion yuan [1] - BGI Genomics has experienced a cumulative increase of 15.85% over the past three days, indicating strong market performance [1] - The company specializes in the life sciences and biotechnology sectors, focusing on the research, production, and sales of instruments, reagents, and consumables, with 90.89% of its revenue coming from sales [1] Group 2 - Longcheng Fund has a significant holding in BGI Genomics, with its Longcheng Consumption Value Mixed A Fund reducing its stake by 300,000 shares but still holding 932,000 shares, representing 7.65% of the fund's net value [2] - The fund has generated a floating profit of approximately 3.728 million yuan today and a total of 10.0469 million yuan during the three-day stock price increase [2] - Longcheng Consumption Value Mixed A Fund has achieved a year-to-date return of 22.7% and a one-year return of 49.42%, ranking 65th out of 8,836 in its category [2]